Ciitech3 Dec 2021 10:02
CiiTECH Investment Highlights
1. Trusted branded cannabis healthcare company with high-quality brands in market
o PROVACAN: CiiTECH's flagship brand, is a leading CBD brand in the UK and loved in over 100 countries, with over 75k customers.
o IMPACT: CBD sports brand for high-impact athletes. Key market: South Africa.
o HUGG: CBD cosmetics brand for women.
2. Early mover advantage in fast-growing UK CBD market [1]
o Over £7m revenue generated in UK since inception in 2018.
o Demand for CBD soars during lockdown as UK market in 2021 now estimated at £690m up from previous £526m estimate and up over 2x from £314m in 2019.
o UK has become world’s 2nd largest consumer cannabinoid market, after the US.
o UK spends more on cannabis extracts than Vitamin B & C combined.
3. Strong development pipeline
o Launching PROVACAN THC Medical Cannabis products in Israel in Q1 2022. Followed by UK rollout Q2/Q3 2022.
o LABOTANIX: Q2 launch in UK. Value CBD brand.
o PROPAWS: Q3 launch in South Africa. CBD for pets.
o PROVACAN Terpene Tincture: COVID treatment oil, developed in conjunction with Technion Israel Institute of Technology.
4. Asset-light model
o CiiTECH develops and controls its brands & IP.
o CiiTECH manages their proprietary B2C & B2B sales platforms.
o Outsourced operations: ingredients supply, packaging, product supply & logistics.
5. Global footprint with agile market entry
o UK: initial and largest market & Top Co.
o Israel: R&D centre - JV with Hebrew University & Multidisciplinary Centre for Cannabinoid Research. Patent application made for potential to treat obesity & diabetes.
o Brazil: Compassionate use for CBD - over 1,000 prescriptions fulfilled in 2020.
o South Africa: strong Rugby ties. Ambassadors: Frankie Horn & Naas Botha. Rugby Clubs including Pirates.
6. Robust, diversified approach to regulation
o Full compliance with Novel Foods in the UK.
o Every CiiTECH supplier seeking Novel Food validation, mitigating risk.
o UK has the most evolved regulatory framework (Food Standards Agency) in the world for CBD, creating a significant moat for highly compliant players like CiiTECH.
7. Proven CBD wellness execution with strong financial performance
o £3m revenue generated in 2020.
8. Strong, Management team with deep experience in cannabinoids & regulated industries
o Chairperson Nava Sofer, over 30 years of international business experience in Europe, the US, Canada, Israel, and Asia.
o Founder & CEO, Clifton Flack, has 25 Years Senior & C-Level Marketing positions. Formerly McCann Erickson & CannaTech Co-Founder.
o CFO, Steve Graubart (CFA), 40 years Senior & C-Level Finance & Venture positions. Formerly EY, ISS & Calvert. Responsible for multiple exits.
o Scientific A
Sign In
Follow the stocks
